Quotes 5-day view Delayed Australian Stock Exchange
02/02/2023
02/03/2023
02/06/2023
02/07/2023
02/08/2023
Date
216.9(c)
221.96(c)
220.28(c)
216.89(c)
216.38
Last
110 251
134 507
88 234
70 269
85 720
Volume
+2.07%
+2.33%
-0.76%
-1.54%
-0.24%
Change
Estimated financial data (e) AUD USD
Sales 2023
1 833 M
1 268 M
1 268 M
Net income 2023
291 M
202 M
202 M
Net cash position 2023
571 M
395 M
395 M
P/E ratio 2023
49,1x
Yield 2023
1,47%
Sales 2024
2 052 M
1 420 M
1 420 M
Net income 2024
346 M
239 M
239 M
Net cash position 2024
632 M
437 M
437 M
P/E ratio 2024
41,7x
Yield 2024
1,70%
Capitalization
14 267 M
9 874 M
9 874 M
EV / Sales 2023
7,47x
EV / Sales 2024
6,64x
Nbr of Employees
4 500
Free-Float
99,5%
Cochlear Limited is an Australia-based company, which provides implantable hearing solutions and sound processors. The Company designs and offers products and accessories for adults or children. The Company operates through three segments: Cochlear implants, Services and Acoustics. The Company’s Cochlear implants segment offers Cochlear implant systems, including Cochlear Nucleus Profile Plus with Slim Modiolar...
Ratings of Cochlear Limited
All news about COCHLEAR LIMITED
News in other languages on COCHLEAR LIMITED
ETFs positioned on COCHLEAR LIMITED ETFs and Trackers with Trackinsight
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends COCHLEAR LIMITED
Short Term Mid-Term Long Term Trends Bullish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
216,89 AUD
Average target price
216,05 AUD
Spread / Average Target
-0,39%
Please enable JavaScript in your browser's settings to use dynamic charts.